Teri Thomas - Volpara Health MD CEO

VPAHFDelisted Stock  USD 0.74  0.00  0.00%   

Insider

Teri Thomas is MD CEO of Volpara Health Technologies
Phone64 4 499 6029
Webhttps://www.volparahealth.com

Volpara Health Management Efficiency

The company has return on total asset (ROA) of (0.1099) % which means that it has lost $0.1099 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2198) %, meaning that it generated substantial loss on money invested by shareholders. Volpara Health's management efficiency ratios could be used to measure how well Volpara Health manages its routine affairs as well as how well it operates its assets and liabilities.
Volpara Health Technologies has accumulated 2.77 M in total debt with debt to equity ratio (D/E) of 0.05, which may suggest the company is not taking enough advantage from borrowing. Volpara Health Techn has a current ratio of 1.43, which is within standard range for the sector. Debt can assist Volpara Health until it has trouble settling it off, either with new capital or with free cash flow. So, Volpara Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Volpara Health Techn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Volpara to invest in growth at high rates of return. When we think about Volpara Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Benjamin Hindson10X Genomics
49
Kate JensenDefinitive Healthcare Corp
38
Marshall MohrVeeva Systems Class
65
George BrooksTeladoc
N/A
Jim Wilbur10X Genomics
N/A
Yulun WangTeladoc
59
Richard NapolitanoTeladoc
57
Michael SturmerProgyny
47
Tina HuntVeeva Systems Class
53
Michael DavidoffPhreesia
51
Julie StadlbauerProgyny
N/A
Jaap MandemaCertara
N/A
Vina LeiteGoodrx Holdings
54
Mike WatersTeladoc
N/A
Michael SchnallLevin10X Genomics
N/A
Allison HoffmanPhreesia
53
Glen TullmanTeladoc
N/A
Jonathan Schimmel10X Genomics
N/A
Douglas HirschGoodrx Holdings
53
Edward CahillPhreesia
67
Ato GarrettVeeva Systems Class
N/A
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand. Volpara Health operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 189 people. Volpara Health Technologies [VPAHF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading.

Management Performance

Volpara Health Techn Leadership Team

Elected by the shareholders, the Volpara Health's board of directors comprises two types of representatives: Volpara Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Volpara. The board's role is to monitor Volpara Health's management team and ensure that shareholders' interests are well served. Volpara Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Volpara Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tana Isaac, Ex Technology
Pr Karssemeijer, CoFounder Board
Jill Spear, Ex Marketing
JD BSc, Joint Counsel
Teri Thomas, MD CEO
Gareth Beaumont, Chief Officer
Julian Marshall, Chief Marketing Officer
Craig Hadfield, CFO, Joint Company Secretary
Kathryn Greene, Chief Officer

Volpara Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Volpara Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Volpara Pink Sheet

If you are still planning to invest in Volpara Health Techn check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Volpara Health's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk